According to the "List of Top 50 Rapid-developed High-technology Chinese Enterprises in 2019" issued by Deloitte, Chengdu Suncadia Medicine Co., Ltd. in Tianfu Life Science Park ranked second in China.

The Top 50 Rapid-developed High-technology Chinese Enterprises & Future Star Selection, reputed as the "Oscar Award of Science and Technology", has been successively held for 14 years to explore excellent enterprises which focus on rapid development and continuous innovation.

On November 20, 2019, Deloitte China made joint efforts with Chengdu Hi-tech Zone to release the list of winners of the 15^th "Top 50 Rapid-developed High-technology Chinese Enterprises" (hereinafter referred to as "Top 50 Chinese Enterprises") & "Future Star Selection" and issued an annual report titled Top 50 Rapid-developed High-technology Chinese Enterprises & Future Star in 2019 on the same day.

The top three of this year's "Top 50 Chinese Enterprises" are respectively Shanghai Qiyu Information Technology Co., Ltd., Chengdu Suncadia Medicine Co., Ltd. and Social Power Information Technology (Shanghai) Co., Ltd..

The report shows that the median growth rate of three-year accumulative operating revenue of Top 50 Chinese Enterprises has been continuously increased in recent years from 357% in 2013 to 1,887% in 2019. Moreover, the scale of operating revenue has been increased significantly compared with the same period last year, and the proportion of enterprises with operating revenue of over RMB 500 million reaches 26% as high.

List of Top 50 Rapid-developed High-technology Chinese Enterprises in 2019

It is noted that Chengdu Suncadia Medicine Co., Ltd. in Chengdu Hi-tech Zone ranked second among Top 50 Chinese Enterprises. Chengdu Suncadia Medicine Co., Ltd. was established on March 23, 2011 in Tianfu Life Science Park in Chengdu Hi-tech Zone. As a subsidiary of Jiangsu Hengrui Medicine Co., Ltd., the company focuses on the development of innovative drugs with independent intellectual property and the research on high-quality generic drugs and develops anti-neoplastic drugs, surgical medicine and drugs for treating several diseases, realizing rapid development in the life science industry.

It is learned that Deloitte's Top 50 Rapid-developed High-technology Enterprises Program was originated in Silicon Valley and is held synchronously every year in dozens of countries like USA, China, Germany, Japan and Australia. It has been honored by the Financial Times and mainstream media at home and abroad as "Benchmark of Global Rapid-developed Enterprises". Numerous internationally-renowned enterprises have been included in Top 50 Rapid-developed High-technology Enterprises when they were start-ups.